Literature DB >> 8386281

Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells.

S Borzakian1, I Pelletier, V Calvez, F Colbere-Garapin.   

Abstract

Poliovirus mutants selected in persistently infected human neuroblastoma cells have a modified cell tropism and can establish a secondary persistent infection in nonneural cells, such as HEp-2c cells. Nucleotide sequence analysis revealed that the genome of a persistent mutant, S11, differed from that of the parental lytic Sabin 1 poliovirus strain by 31 point mutations. Three mutations occurred in the noncoding regions. The other mutations resulted in 12 amino acid substitutions; 1 substitution occurred in a nonstructural protein (3A), while the other 11 substitutions were clustered in the capsid proteins VP2 and VP1. The same missense mutations, as well as many of the silent mutations that we observed in mutant S11, also accumulated in the genome of two other persistent viruses isolated from independent infections. This finding indicates that both missense and silent mutations are selected during the persistent infection of neuroblastoma cells and suggests that the secondary structure of RNA in the coding region may play a role in viral infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386281      PMCID: PMC237618     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Poliovirus antigenic hybrids simultaneously expressing antigenic determinants from all three serotypes.

Authors:  A D Murdin; H H Lu; M G Murray; E Wimmer
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

2.  High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus.

Authors:  J C de la Torre; C Giachetti; B L Semler; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

4.  Prolonged intracerebral infection with poliovirus in asymptomatic mice.

Authors:  J R Miller
Journal:  Ann Neurol       Date:  1981-06       Impact factor: 10.422

Review 5.  The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review.

Authors:  E Domingo; E Martínez-Salas; F Sobrino; J C de la Torre; A Portela; J Ortín; C López-Galindez; P Pérez-Breña; N Villanueva; R Nájera
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12.

Authors:  F Colbere-Garapin; S Chousterman; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  Late motor neuron degeneration following poliomyelitis.

Authors:  A M Campbell; E R Williams; J Pearce
Journal:  Neurology       Date:  1969-11       Impact factor: 9.910

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Determination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome.

Authors:  C D Ward; J B Flanegan
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  Host range determinants located on the interior of the poliovirus capsid.

Authors:  E G Moss; V R Racaniello
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  17 in total

1.  Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; J Balanant; A Macadam; D Otelea; M Combiescu; A A Combiescu; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Antiviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase occur in specific RNA structural regions.

Authors:  R F Schinazi; R M Lloyd; C S Ramanathan; E W Taylor
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

3.  Type I Interferon acts as a major barrier to the establishment of infectious bursal disease virus (IBDV) persistent infections.

Authors:  Laura Broto; Nicolás Romero; Fernando Méndez; Elisabet Diaz-Beneitez; Oscar Candelas-Rivera; Daniel Fuentes; Liliana L Cubas-Gaona; Céline Courtillon; Nicolas Eterradossi; Sébastien M Soubies; Juan R Rodríguez; Dolores Rodríguez; José F Rodríguez
Journal:  J Virol       Date:  2020-12-16       Impact factor: 5.103

4.  Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro.

Authors:  W Chen; R S Baric
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells.

Authors:  Frederik Beaulieux; Youssef Zreik; Christelle Deleage; Valerie Sauvinet; Vincent Legay; Pascale Giraudon; Katherine M Kean; Bruno Lina
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

6.  Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.

Authors:  T Couderc; N Guédo; V Calvez; I Pelletier; J Hogle; F Colbère-Garapin; B Blondel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence.

Authors:  W Chen; R S Baric
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Subclonal components of consensus fitness in an RNA virus clone.

Authors:  E A Duarte; I S Novella; S Ledesma; D K Clarke; A Moya; S F Elena; E Domingo; J J Holland
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Rapid cell variation can determine the establishment of a persistent viral infection.

Authors:  A M Martín Hernández; E C Carrillo; N Sevilla; E Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Persistent equine arteritis virus infection in HeLa cells.

Authors:  Jianqiang Zhang; Peter J Timoney; N James MacLachlan; William H McCollum; Udeni B R Balasuriya
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.